Eva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies ...
Medical use claims under the European Patent Convention (EPC) are considered to include the therapeutic effect as a functional technical feature and are therefore limited to the achievement of such an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback